-

Fresenius Kabi Announces 13 New Inductees Into the National Blood Donation Hall of Fame

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today the induction of 13 new honorees into the National Blood Donation Hall of Fame.

Congratulations to the 2025 inductees of the Fresenius Kabi National Blood Donation Hall of Fame.

Share

Nominated by blood centers across the United States, the honorees have demonstrated extraordinary commitment to donating blood or for inspiring others to give. Each inductee has made a remarkable contribution to the nation’s blood supply, whether through a lifetime of donations or through advocacy that has motivated entire communities to give.

“Blood donation is one of the most selfless gifts a person can give, and each of this year’s inductees embodies that spirit of generosity,” said Eddie Kubo, Senior Vice President, Commercial Operations, MedTech Division, Fresenius Kabi North America. “Through their commitment and advocacy, they have helped ensure a steady and safe blood supply for patients in need, and we are proud to honor their contributions.”

This year’s inductees include individuals who began donating after a family member or friend received a life-saving transfusion, those who organize blood donation drives in memory of loved ones, and others who give blood to strengthen community bonds.

With this year’s honorees, more than 300 individuals have been inducted into the Fresenius Kabi National Blood Donation Hall of Fame during the past 27 years. The program celebrates the stories of blood donors nationwide and shines a spotlight on the vital role blood donation plays in saving lives. 2025 inductees include:

  • A high school student who not only donates regularly but also encourages classmates to join him. Despite personal challenges and even a fear of blood, he faces each donation with courage, inspiring first-time donors and fostering a culture of giving in his community.
  • A woman who has now made more than 400 lifetime donations to honor her late husband’s memory while inspiring generations of students and community members.
  • A mother who began donating blood at the age of 16 but became more aware of its importance when her two sons required countless transfusions for a rare genetic disease. She now hosts multiple blood drives each year and even created a short film to inspire others to make long-term commitments to donation.

The 2025 inductees and their nominating blood centers are:

  • DANIEL ROGERS – OneBlood, Tampa, Fla.
  • CAROL WEAVER – Versiti Blood Center of Indiana, Indianapolis, Ind.
  • JAMES E. SWOBODA SR. – American Red Cross, West Omaha, Neb.
  • TAMMY VICKERS AND TRACI HARPER – OneBlood, Douglas, Ga.
  • BRENNA TEERLINCK – ImpactLife, Davenport, Iowa
  • MINDY SUE JONES – Versiti Blood Center of Ohio, Dayton, Ohio
  • GERALD H. YAMANE – Blood Bank of Hawaii, Honolulu, Hawaii
  • LATORRA GARLAND – Carter BloodCare, Bedford, Texas
  • JEREMY HURLEY – Our Blood Institute, Oklahoma City, Okla.
  • SARAH FULLER – Vitalant, Denver, Colo.
  • BLAKE LAVERDIERE – Rhode Island Blood Center, an operating division of New York Blood Center Enterprises, Providence, R.I.
  • KRISTINE OUIMET – American Red Cross, Pleasant Hill, Calif.

Each year, the National Blood Donation Hall of Fame honorees are featured in a commemorative donation interval calendar shared with blood centers nationwide, celebrating their inspiring stories and contributions. To learn more about the 2025 inductees, visit the National Blood Donation Hall of Fame website. To locate a nearby donation center and make an appointment, go to DonatingBlood.org.

About Fresenius Kabi

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. With more than 41,000 employees and present in more than 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.

In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.

Fresenius Kabi takes a holistic approach to health care and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.

Fresenius Kabi is part of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.

For more information, please visit www.fresenius-kabi.com/us. To learn about U.S. career opportunities at Fresenius Kabi, visit us at www.fresenius-kabi.com/us/join-us and follow us on LinkedIn and Facebook.

Contacts

Media contact
Matt Kuhn (847) 220-3033
matt.kuhn@fresenius-kabi.com

Fresenius Kabi


Release Versions

Contacts

Media contact
Matt Kuhn (847) 220-3033
matt.kuhn@fresenius-kabi.com

Social Media Profiles
More News From Fresenius Kabi

Fresenius Kabi and AABB Announce 21st Annual Blood Collectors Week, September 6–12, 2026, Honoring Lifesaving Blood Collection Professionals

LAKE ZURICH, Ill. & BETHESDA, Md.--(BUSINESS WIRE)--Fresenius Kabi and the Association for the Advancement of Blood & Biotherapies (AABB) announced today the launch of the 21st annual Blood Collectors Week, taking place September 6–12, 2026. The annual recognition week celebrates the blood collection professionals whose expertise and dedication help ensure patients across the country have access to safe, high-quality blood and blood components. Blood Collectors Week honors the essential pro...

Fresenius Kabi Launches Generic Sugammadex in Simplist® Ready‑to‑Administer Prefilled Syringe in the U.S.

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a global healthcare company part of the Fresenius Group, specializing in lifesaving therapies and technologies, today announced the U.S. launch of the FDA‑approved generic Sugammadex Injection. Exclusivity for the branded medicine Bridion® (Merck) expired in July 2026. Fresenius Kabi offers operating room clinicians Sugammadex in a Simplist® ready-to-administer prefilled syringe. Simplist® single-dose, prefilled syringes require no assembly at...

Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of the Fresenius Group, is recalling one lot of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL)20 mL vials to the user level. An internal investigation at the firm found the product to contain glass particles. Risk Statement: The administration of an injectable product containing glass particulates may cause local irritation, pain, or swelling at the infusion site, as well as inflammation of the veins. More se...
Back to Newsroom